Event

• November 17: AI-Powered HEOR: Advancing Insights and Decisions with Large Language Models - In Person at ISPOR Europe 2024

  17 November, 2024, 7 AM-11 AM

• November 17: Going Beyond the Standard: Exploring Advanced Survival Modeling Techniques - In Person at ISPOR Europe 2024

  17 November, 2024, 7 AM-11 AM

• November 17: Health Technology Assessment for Rare Diseases - In Person at ISPOR Europe 2024

  17 November, 2024, 7 AM-11 AM

• November 17: Introduction to Machine Learning Methods - In Person at ISPOR Europe 2024

  17 November, 2024, 7 AM-11 AM

• November 17: Valuation of Innovative Drugs - In Person at ISPOR Europe 2024

  17 November, 2024, 2 AM-6 AM

• November 17: Core Concepts and Approaches to Early-Stage Health Technology Assessment - In Person at ISPOR Europe 2024

  17 November, 2024, 2 AM-6 AM

• November 17: Reimbursement Systems for Pharmaceuticals in Europe - In Person at ISPOR Europe 2024

  17 November, 2024, 2 AM-11 AM

• November 17: Developing Decision-Grade Real-World Evidence - In Person at ISPOR Europe 2024

  17 November, 2024, 2 AM-6 AM

• November 17: Introduction to Applied Generative AI for HEOR - In Person at ISPOR Europe 2024

  17 November, 2024, 2 AM-6 AM

• November 17: Introduction to Health Economics and Outcomes Research - In Person at ISPOR Europe 2024

  17 November, 2024, 2 AM-11 AM

• November 17: Real-World Evidence in External Control Arms: Driving Innovation in Drug Development - In Person at ISPOR Europe 2024

  17 November, 2024, 2 AM-6 AM

• November 17: Causal Inference and Causal Estimands From Target Trial Emulations Using Evidence from Real-World Observational Studies and Clinical Trials - In Person at ISPOR Europe 2024

  17 November, 2024, 2 AM-6 AM

• November 17: Health Economic Modeling in R: A Hands-on Introduction - In Person at ISPOR Europe 2024

  17 November, 2024, 2 AM-6 AM

• The Burden of Time: MS Treatment and Socio-Economic Impact Reduction

  30 October, 2024, 9 AM-10 AM

• IRA Part III: Medicare’s Maximum Fair Prices for the First 10 Negotiated Drugs and Anticipated Cost Savings

  22 October, 2024, 10 AM-11 AM

• October 16-17: Applying RWD and Novel Data Sources to Advance Patient-Centric Health Equity, Outcomes, and Economic Evaluations- Virtual

  Everyday, 16 October, 2024 at 10 AM-17 October, 2024 at 12 PM

• Evidence Generation for JCAs: How Can AI Boost Efficiency and Maintain Quality?

  16 October, 2024, 10 AM-11 AM

• Global Perspective on Inequality Aversion: Methods and Learnings

  15 October, 2024, 6 PM-7 PM

• Patient Involvement in Value and Health Technology Assessment (V/HTA)

  10 October, 2024, 10 AM-11:30 AM

• Conducting Research and Survey Studies in Hard-to-Reach Populations

  9 October, 2024, 10 AM-11 AM

• 1
• 2
• 3 (current)
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »